Kolexia
Garidi Reda Hématologie
Garidi Reda
Hématologie
Ch Saint-quentin
Saint-Quentin, France
99 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Myélome multiple Tumeurs du système nerveux central Lymphome à cellules du manteau Lymphome T Tumeurs à plasmocytes Récidive tumorale locale Néphrocarcinome Lymphome T périphérique

Collaborateurs

Voir plus
Chehimi Mohamad
Chehimi Mohamad
Ch Saint-quentin, Saint-Quentin, France
Bouketouche Malek
Bouketouche Malek
Centre Hospitalier de Laon, Laon, France
Coppin Céline
Coppin Céline
Cabinet libéral, Rumilly-en-Cambrésis, France
Gressin Remy
Gressin Remy
Hôpital Nord Grenoble, La Tronche, France

Industries

Voir plus
Sobi
20 collaboration(s)
Dernière en 2023
A+A
18 collaboration(s)
Dernière en 2023
Novartis
11 collaboration(s)
Dernière en 2022
AstraZeneca
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Janssen Hématologie /.Pr GARIDI Reda: cancérologie France
Youtube @ Santé News   01 décembre 2023
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica   30 novembre 2023
Pr. Garidi Reda - France
Youtube @ SAHTS   01 novembre 2023
TRANSCRIPT: Transplantation After Complete Response In Patients With T-cell Lymphoma
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023
VITALIZE: A Phase 2b, Open-label, Multicenter, Randomized Parallel-Group, Two-Stage, Study of an Immunotherapeutic Treatment DPX-Survivac and Pembrolizumab, With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (VITALIZE)
Essai Clinique (ImmunoVaccine Technologies, Inc. (IMV Inc.))   05 avril 2023
Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
British journal of haematology   17 février 2023
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 juillet 2022
Radiotherapy (WBRT) or Autologous Stem-Cell Transplantation (ASCT) for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Long-Term Results of the Intergroup Anocef-Goelams Randomized Phase II Precis Study
Blood   23 novembre 2021
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial.
The Lancet. Oncology   13 septembre 2021